Imac Holdings (BACK) AI Stock Analysis

• Market Cap: $370.93K
• Dividend Yield: N/A
• Average Volume (3M): 10.92K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.04
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 15
• Sector: Healthcare
• Sector Strength: 50
• Industry: Medical - Care Facilities
• EPS (TTM): -5.99
• Shares Outstanding: 3,784,966
• 10 Day Avg. Volume: 11,780
• 30 Day Avg. Volume: 10,920
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 25 Underperform
• Price Target: ―

IMAC Holdings has a low overall stock score due to significant financial challenges, negative valuation metrics, and technical indicators suggesting weak momentum. The risk of Nasdaq delisting further exacerbates the company's precarious position. The lack of earnings call data limits further insights into potential strategic actions or improvements.

Imac Holdings Business Overview & Revenue Model

Company Description

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

How the Company Makes Money

IMAC Holdings generates revenue primarily through the operation of its medical clinics, which provide a range of healthcare services such as physical therapy, chiropractic care, and regenerative medicine treatments. These services cater to patients seeking alternatives to traditional surgical procedures, allowing the company to capture a niche market within the healthcare industry. Revenue is driven by patient visits, treatment plans, and insurance reimbursements. Additionally, the company may engage in partnerships or collaborations with healthcare providers and specialists to expand its service offerings and reach a broader customer base. While specific financial data and partnerships were not available, the company's focus on innovative care solutions positions it to capitalize on growing demand for non-invasive healthcare options.

Imac Holdings Financial Statement Overview

Summary

IMAC Holdings is facing substantial financial difficulties across income, balance sheet, and cash flow metrics. The company struggles with declining revenues and continuous losses, reflected in negative profit margins and equity. Despite no debt in the TTM, the lack of cash generation and equity poses a significant risk to financial health and sustainability.

Income Statement

The company has been experiencing significant revenue declines, with a negative revenue growth rate in the TTM. Profit margins are severely negative across all major metrics, indicating ongoing operational challenges. Gross profit margin, net profit margin, EBIT, and EBITDA margins are all unfavorable, underscoring the lack of profitability.

Balance Sheet

The balance sheet reveals minimal stockholders' equity, leading to high leverage. However, the absence of debt in the TTM indicates no immediate financial liabilities, which could mitigate some risks. ROE is negative due to persistent net losses, and the equity ratio is extremely low, highlighting financial instability.

Cash Flow

Cash flow performance is concerning, with substantial negative operating and free cash flows in the TTM. The free cash flow growth rate is negative, marking a worsening situation. Operating and free cash flow to net income ratios are not favorable, indicating poor cash generation relative to losses.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	223.60K	72.05K	5.20M	16.19M	14.39M	12.84M
Gross Profit	-184.68K	-233.20K	3.85M	14.68M	12.76M	11.21M
EBITDA	-7.37M	-5.48M	-5.95M	-10.20M	-8.39M	-3.26M
Net Income	-10.84M	-9.05M	-9.42M	-26.74M	-11.10M	-5.57M
Balance Sheet
Total Assets	1.14M	1.59M	1.14M	11.08M	27.23M	19.75M
Cash, Cash Equivalents and Short-Term Investments	30.88K	504.19K	221.51K	763.21K	7.12M	2.62M
Total Debt	531.47K	0.00	0.00	4.16M	5.90M	9.14M
Total Liabilities	8.77M	7.98M	1.90M	6.43M	9.28M	11.93M
Stockholders Equity	-7.63M	-6.39M	-752.65K	4.65M	17.95M	10.43M
Cash Flow
Free Cash Flow	-3.99M	-3.16M	-2.79M	-10.63M	-8.35M	-6.36M
Operating Cash Flow	-3.99M	-3.16M	-2.79M	-10.29M	-7.59M	-5.99M
Investing Cash Flow	-375.00K	-375.00K	-1.78M	-259.98K	-2.46M	-569.74K
Financing Cash Flow	4.38M	3.82M	4.02M	4.20M	14.54M	8.81M

Imac Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.08
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BACK, the sentiment is Positive. The current price of 0.08 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.06, and below the 200-day MA of 0.49, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 55.41 is Neutral, neither overbought nor oversold. The STOCH value of 59.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BACK.

Imac Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TOI	55 Neutral	$351.58M	―	-535.24%	―	17.53%	14.49%
AMS	52 Neutral	$17.06M	11.72	-9.49%	―	26.61%	-156.30%
JYNT	52 Neutral	$161.87M	―	-16.16%	―	-40.65%	85.56%
Sector *	50 Neutral	AU$2.63B	3.17	10.94%	2.68%	36.93%	13.65%
PIII	46 Neutral	$48.69M	―	-138.17%	―	4.20%	-54.16%
SYRA	45 Neutral	$939.61K	―	-64.70%	―	14.07%	76.85%
BACK	25 Underperform	$370.93K	―	1251.39%	―	―	―

Imac Holdings Corporate Events

IMAC Holdings Faces Nasdaq Compliance Challenges

IMAC Holdings, Inc. recently received notices from Nasdaq regarding non-compliance with listing rules due to an incomplete audit committee and delayed filing of a required quarterly report. Although these issues have not yet impacted the trading of IMAC’s stock, the company is working on a plan to address these deficiencies. Investors should be aware that failure to comply could lead to delisting, but IMAC intends to meet Nasdaq’s requirements within the given timelines.